Oxford BioDynamics Plc

0.10pAs of Sun 8 Nov 2026, 12:00 UTC
LSE:OBDHealthcare
Ctry United Kingdom
PE (Fwd) •••
TSR 10Y CAGR (52.44%)
Div yield —
ROE (214.95%)
Biotechnology
Beta (5Y) (0.20)
PE TTM —
TSR TTM (68.75%)
Mkt cap £13.44M
ROIC (64.19%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
0.114p
13.99%
(68.87%)
Hold 5|3|9|3|0
1Q26
2Q26
3Q26
4Q26
Earnings per share£
—
—
—
—
(1.32%)
(1.90%)
8.45%
7.57%
Revenue£M
0.797
0.842
0.827
0.820
13.38%
16.39%
11.45%
4.80%
Peers (US$18.09M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.846
1.435
1.244
EBIT/Intx
0.625
0.508
0.500
Own earn%
(29.48)
34.25
30.72
Sh yield%
46.90
29.15
27.44
Owners
Insiders/Inst%
9.53
51.75
Short interest%
1.04
SBC / revenue%
0.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
5–10
$1 testx
−1.1
Incr. ROIC%
0